Ver­tex strikes $4.9B deal for Alpine, ex­pand­ing work in kid­ney and au­toim­mune dis­ease

Last year
Deals

In­vestors aren't back­ing fer­til­i­ty star­tups like they used to — part of dig­i­tal health's re­set

Last year
Financing
Health Tech

Eu­ro­pean Par­lia­ment adopts phar­ma leg­isla­tive re­vamp by wide mar­gin

Last year
Pharma

Ex­clu­sive: Genen­tech plans to cut 3% of work­force across sev­er­al units, com­pa­ny says

Last year
People
Pharma

FDA open to use of new MRD end­point ahead of ad­vi­so­ry com­mit­tee meet­ing

Last year
Pharma
FDA+

Alpine Im­mune Sci­ences, Janux said to be look­ing at pos­si­ble sales — re­ports

Last year
Deals
Pharma

Phar­ma, health and well­ness judges named for 2024 Cannes Li­ons cre­ative awards

Last year
Pharma
Marketing

En­do sues FDA over its han­dling of gener­ic Adren­a­lin ap­provals

Last year
Pharma
FDA+

UCB en­lists re­al pa­tients in new hidradeni­tis sup­pu­ra­ti­va cam­paign as it awaits Bimzelx de­ci­sion

Last year
Pharma
Marketing

Sanofi to di­vest can­cer biotech it bought for $1B, axe 100 staffers in Cal­i­for­nia

Last year
People
Deals

Ear­ly can­cer vac­cine da­ta breathe new life in­to the field, but many ques­tions re­main: #AACR24

Last year
R&D

Skye Bio­science up­lists; On­coX's li­cens­ing deal with AB­VC Bio­Phar­ma

Last year
News Briefing

Ex­clu­sive: Top lob­by­ist at BIO leaves as trade group grap­ples with US-Chi­na ten­sions

Last year
People
FDA+

An­oth­er ADC biotech reels in big bucks as Mark Alles’ TORL nabs $158M

Last year
Financing
Startups

Gink­go, No­vo Nordisk forge ‘flex­i­ble’ re­search pact, from dis­cov­ery to man­u­fac­tur­ing

Last year
Deals
Manufacturing

No­var­tis paus­es en­roll­ment for Kisqali breast can­cer tri­als to align with ni­trosamine guide­lines

Last year
R&D
Manufacturing

Big come­back? The Q1 re­port on biotech is in, and there’s been some sput­ter­ing

Last year
Financing
Deals

As­traZeneca's ‘ra­diosen­si­tiz­er’ may en­hance ef­fi­ca­cy of ra­di­a­tion for dead­ly brain can­cer: #AACR24

Last year
R&D

Ex­clu­sive: Sanofi to close Dutch NK cell ther­a­py biotech ac­quired in 2020

Last year
R&D
Pharma

La­dy Gaga re­turns in a new Nurtec mi­graine ad for Pfiz­er

Last year
Pharma
Marketing

No­var­tis, Sanofi and PhRMA push FDA on how to bet­ter han­dle com­plex tri­al de­signs

Last year
Pharma
FDA+

No­var­tis to re­duce de­vel­op­ment team by near­ly 700 po­si­tions

Last year
People
Pharma

Vir­ginia gov­er­nor ve­toes bill to cre­ate ad­vi­so­ry board to re­duce drug prices

Last year
Pharma
FDA+

In­di­an phar­ma re­ceives FDA warn­ing let­ter for bare­foot em­ploy­ees and gen­er­al 'dis­re­pair'

Last year
Pharma
FDA+
First page Previous page 173174175176177178179 Next page Last page
A service from the Financial Times